Omega 3 pentaenoic acid
MAT-002
Phase 2 small_molecule completed
Quick answer
Omega 3 pentaenoic acid for Hypertriglyceridemia is a Phase 2 program (small_molecule) at Matinas BioPharma Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Matinas BioPharma Holdings
- Indication
- Hypertriglyceridemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed